Nir Bhatt

Nir Bhatt leads mRNA process development for personalized cancer vaccines, working to compress the manufacturing timeline from tumor sequencing to patient administration. His engineering work has optimized GMP production of individualized mRNA cancer vaccines like mRNA-4157, enabling scale-out to large clinical trial populations. He has developed quality control frameworks for highly variable personalized mRNA vaccine products. His work in manufacturing science is as critical as the biology for making personalized mRNA vaccines clinically viable.